Literature DB >> 3732314

Ataxia telangiectasia with generalized skin pigmentation and early death.

M Tsukahara, M Masuda, K Ohshiro, K Kobayashi, T Kajii, Y Ejima, M S Sasaki.   

Abstract

A female infant with clinical and laboratory features of ataxia telangiectasia (AT) showed two clinical features exceptional for the disease, i.e. generalized skin pigmentation and an unusually early death at the age of 15 months. Her clinical features supportive of the diagnosis of AT included growth and developmental retardation and muscle weakness. Findings indicating immunodeficiency included recurrent pulmonary infections, failure of PHA stimulation of PB lymphocytes, decreased levels of serum IgM and IgA and on autopsy, an atrophic thymus without Hassall's corpuscles. Her cultured skin fibroblasts showed increased spontaneous chromosome breakages and hypersensitivity to X-ray irradiation, as would be expected for AT fibroblasts. She showed elevated blood HbF levels, macrocytic anaemia, granulocytopenia and thrombocytopenia, findings suggestive of a preleukaemic or leukaemic process. Yet aspirates of her bone marrow revealed no malignant cells. Autopsy revealed bilateral Pneumocystis carinii pneumonia, telangiectatic lesions in all the internal organs studied, sparse and degenerative Purkinje cells in the cerebellar cortex and atrophic ovaries. In view of these findings, it was concluded that the patient had a hitherto undescribed variant of ataxia telangiectasia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732314     DOI: 10.1007/bf00441871

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

Review 1.  Genetic and biochemical studies with ataxia telangiectasia. A review.

Authors:  P C Huang; R B Sheridan
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

2.  A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.

Authors:  M S Sasaki; A Tonomura
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

3.  Ataxia-telangiectasia.

Authors:  D E McFarlin; W Strober; T A Waldmann
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

4.  A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy.

Authors:  F P Li; N U Potter; G R Buchanan; G Vawter; J Whang-Peng; R B Rosen
Journal:  Am J Med       Date:  1978-12       Impact factor: 4.965

5.  Cutaneous manifestations of ataxia-telangiectasia.

Authors:  W B Reed; W L Epstein; E Boder; R Sedgwick
Journal:  JAMA       Date:  1966-02-28       Impact factor: 56.272

6.  [Contribution to the Louis-Bar syndrome (ataxia telangiectasia) (author's transl)].

Authors:  A Tennstedt
Journal:  Zentralbl Allg Pathol       Date:  1978

7.  Ataxia-telangiectasia with a 32 year survival. A clinicopathological report.

Authors:  G D Amromin; E Boder; R Teplitz
Journal:  J Neuropathol Exp Neurol       Date:  1979-11       Impact factor: 3.685

8.  Radiosensitivity of fibroblasts from patients with retinoblastoma and chromosome-13 anomalies.

Authors:  Y Ejima; M S Sasaki; H Utsumi; A Kaneko; H Tanooka
Journal:  Mutat Res       Date:  1982-02       Impact factor: 2.433

9.  Ataxia telangiectasia. Evaluation of radiosensitivity in cultured skin fibroblasts as a diagnostic test.

Authors:  R Cox; G P Hosking; J Wilson
Journal:  Arch Dis Child       Date:  1978-05       Impact factor: 3.791

10.  Ataxia-pancytopenia: syndrome of cerebellar ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia.

Authors:  F P Li; F Hecht; B Kaiser-McCaw; P V Baranko; N U Potter
Journal:  Cancer Genet Cytogenet       Date:  1981-11
  10 in total
  2 in total

1.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

2.  Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseases.

Authors:  Stephan Borte; Magdalena Janzi; Qiang Pan-Hammarström; Ulrika von Döbeln; Lennart Nordvall; Jacek Winiarski; Anders Fasth; Lennart Hammarström
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.